Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Stock Up ∞
The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The business’s 50 day moving average price is C$2.00 and its 200 day moving average price is C$2.00. The firm has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Stories
- Five stocks we like better than Liberty Biopharma
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Are Penny Stocks a Good Fit for Your Portfolio?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is a Secondary Public Offering? What Investors Need to Know
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.